EU to approve import of 17 GM foods as part of trade deal

Seventeen new genetically modified food products will be authorised for import to Europe before the end of May in a significant acceleration of biotech trade, the Guardian has learned.

An announcement could be made as early as next week, sources said, when a meeting of EU commissioners has been pencilled in to review adoption of new rules for approving GM imports.

Europe currently imports around 58 GM products from abroad, mostly US maize, cotton, soy bean and sugar beet.

But Greenpeace said that the US has raised the issue of a large logjam in biotech authorisations in talks over a free trade deal known as TTIP.

“With transatlantic trade talks ongoing, pressure has been mounting from the biotech industry and the U.S. government to break open the EU market to GM imports and to speed up authorisation procedures,” Marco Contiero, Greenpeace EU’s agriculture director, told the Guardian. 

Individual countries would be given a similar opt-out to the one agreed for GM cultivation in a law passed earlier this year.

“This would be another licence to ban safe products,” Beat Späth, the director for agricultural biotechnology at the EuropaBio trade association told the Guardian. “If countries impose unjustified bans on products that have been used by farmers for 15 years, where are our farmers supposed to get their feed from?”

The GLP aggregated and excerpted this blog/article to reflect the variety of news, opinion and analysis. Read full, original post: EU clears path for 17 new GM foods

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
artificial intelligence brain think illustration md
Viewpoint — Digital gods and human extinction: Will we be the first species ever to design our own descendants?
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT Image May 12, 2026, 01_21_30 PM
How big health brands are funding online medical misinformation 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.